Chlorpheniramine Maleate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Chlorpheniramine Maleate
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Chlorpheniramine Maleate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 14 USDMF, 2 JDMF, 5 EU WC, 7 KDMF, 13 NDC API, 26 Listed Suppliers, $ API Reference Price

41 API Suppliers
14 USDMF
2 JDMF
5 EU WC
7 KDMF
13 NDC API
26 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

209 FDF Dossiers, 66 FDA Orange Book, 8 Europe, 34 Canada, 26 South Africa, 75 Listed Dossiers

209 FDF Dossiers
66 FDA Orange Book
8 Europe
34 Canada
26 South Africa
75 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 4MG/5ML;5MG/5ML, TABLET;ORAL - 2MG;200MG;30MG, TABLET;ORAL - 4MG;200MG;10MG, SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 4MG/5ML;5MG/5ML
TABLET;ORAL - 2MG;200MG;30MG
TABLET;ORAL - 4MG;200MG;10MG
SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 2 Evonik, 12 Rochem International Inc, 24 SPI Pharma, 2 Seqens, 27 DKSH, 2 Pharm-RX Chemical, 9 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 2 Kewpie Corporation, 16 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 4 ACG Worldwide, 14 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 37 BASF, 1 Bioplus Life Sciences, 5 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 22 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 47 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

120 Fillers, Diluents & Binders, 75 Coating Systems & Additives, 62 Thickeners and Stabilizers, 53 Solubilizers, 45 Direct Compression, 45 Disintegrants & Superdisintegrants, 45 Taste Masking, 42 Controlled & Modified Release, 36 Topical, 34 Parenteral, 33 Film Formers & Plasticizers, 33 Granulation, 28 Lubricants & Glidants, 23 Chewable & Orodispersible Aids, 19 Co-Processed Excipients, 17 Rheology Modifiers, 16 Emulsifying Agents, 12 API Stability Enhancers, 9 Empty Capsules, 6 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

120 Fillers, Diluents & Binders
75 Coating Systems & Additives
62 Thickeners and Stabilizers
53 Solubilizers
45 Direct Compression
45 Disintegrants & Superdisintegrants
45 Taste Masking
42 Controlled & Modified Release
36 Topical
34 Parenteral
33 Film Formers & Plasticizers
33 Granulation
28 Lubricants & Glidants
23 Chewable & Orodispersible Aids
19 Co-Processed Excipients
17 Rheology Modifiers
16 Emulsifying Agents
12 API Stability Enhancers
9 Empty Capsules
6 Surfactant & Foaming Agents
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
18 NEWS #PharmaBuzz

MARKET PLACE

31 APIs, 3 FDF Dossiers

31 APIs
3 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 USP, 8 JP, 1 Others

1 USP
8 JP
1 Others

$ API Ref.Price (USD/KG) : 40 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 2HALEON US HOLDINGS

02 2MAINPOINTE

filter Patent Number Reset all filters

4 All

01 17863287

02 19066942

03 19107921

04 110238640

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 3Y

02 1Blank

filter Expiration Date Reset all filters

4 All

01 12024-05-25

02 12027-02-28

03 22032-01-03

Product Main Page

01

HALEON US HOLDINGS

CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

BioAsia

Not Confirmed

HALEON US HOLDINGS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-02-28

CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

US Patent Number : 7863287

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21441

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-02-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

HALEON US HOLDINGS

CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

BioAsia

Not Confirmed

HALEON US HOLDINGS

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-05-25

CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE

US Patent Number : 10238640

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21587

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-05-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

MAINPOINTE

CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE

BioAsia

Not Confirmed

MAINPOINTE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-01-03

CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE

US Patent Number : 9066942

Drug Substance Claim :

Drug Product Claim :

Application Number : 206323

Patent Use Code : U-1716

Delist Requested :

Patent Use Description : TREATMENT OF COUGH AND...

Patent Expiration Date : 2032-01-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

MAINPOINTE

CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE

BioAsia

Not Confirmed

MAINPOINTE

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-01-03

CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE

US Patent Number : 9107921

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206323

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-01-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!